亚洲患者经导管主动脉瓣置换术后人工瓣膜-患者不匹配的影响
本研究纳入201例接受CoreValve或Evolut R自膨胀瓣膜植入的亚洲连续患者,30天时评估人工瓣膜-患者不匹配(PPM)。中重度PPM共40例(18.4%中度,1.5%重度)。中位随访30.4个月,PPM与全因死亡、心血管死亡及心衰再住院风险升高相关。
要点
- 亚洲自膨胀瓣膜TAVR后中度PPM 18.4%、重度1.5%。
- PPM预测因素包括女性、较大体表面积、较低LVEF。
- PPM增加中期全因死亡、心血管死亡和心衰再住院风险。
核心结论
- 在亚洲人群中,TAVR后PPM与中期死亡和心衰再住院风险升高相关。
- 术前参考特定瓣膜尺寸的预期有效开口面积有助于避免PPM。
研究设计与样本
- 单中心连续201例接受CoreValve或Evolut R自膨胀瓣膜TAVR的亚洲患者。
- 30天时以核心实验室测量的指数化有效开口面积定义PPM:重度<0.65 cm2/m2,中度0.65-0.85 cm2/m2。
- 采用多变量回归模型分析PPM预测因素及中期死亡和心衰再住院。
主要发现
- 中度PPM 37例(18.4%),重度PPM 3例(1.5%),共40例归入PPM组。
- PPM预测因素包括女性、较大体表面积和较低左心室射血分数。
临床怎么用
- TAVR术前应参考特定瓣膜尺寸的预期有效开口面积,以识别和避免PPM。
- 对女性、体表面积较大或LVEF较低的患者,应尤其关注PPM风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Little is known about the incidence of prosthesis-patient mismatch (PPM) and its impact after transcatheter aortic valve replacement with self-expanding valves in an Asian population. We aimed to assess postprocedural effective orifice area with standardized methods and the impact of PPM on midterm outcomes after CoreValve or Evolut R (Medtronic) implantation in an Asian population. METHODS: Among 201 consecutive patients undergoing CoreValve or Evolut R implantation, PPM was assessed at 30 days and defined based on core laboratory measured indexed effective orifice area as severe (less than 0.65 cm2/m2) or moderate (0.65 to 0.85 cm2/m2). Multivariable regression models were utilized to examine predictors of PPM as well as mortality and rehospitalization for heart failure at midterm follow-up. RESULTS: Moderate and severe PPM were observed after self-expanding valves in 37 patients (18.4%) and 3 patients (1.5%), respectively. These 40 patients were included in the PPM group. Predictors of PPM included female sex, larger body surface area, and lower left ventricular ejection fraction. At midterm (median 30.4 months; interquartile range, 17 to 57.8) follow-up, patients with PPM had an increased risk of all-cause death (adjusted hazard ratio 1.95; 95% confidence interval, 1.08 to 3.53; P = .027), cardiovascular mortality (adjusted hazard ratio 3.38; 95% confidence interval, 1.04 to 10.99; P = .043), and rehospitalization for heart failure (adjusted hazard ratio 2.40; 95% confidence interval, 1.11 to 5.17; P = .025). CONCLUSIONS: Patient-prosthesis mismatch was associated with higher midterm mortality and rehospitalization for heart failure in an Asian population. The expected postprocedural effective orifice area for any given valve size may be helpful in preprocedural decision making to avoid PPM.
引用
- Chen YH, Chang HH, Kuo CC, et al. Impact of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement in Asian Patients. Ann Thorac Surg. 2021. PMID: 34678284. doi:10.1016/j.athoracsur.2021.09.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。